You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fluoropyrimidine cardiotoxicity

Showing 1 - 25 of 347
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cardiovascular Toxicity: Comprehensive Myocardial and Vascular

Recruiting
  • Cardiovascular Diseases
  • +7 more
  • Cardiovascular magnetic resonance with stress perfusion
  • +4 more
  • London, United Kingdom
    St Bartholomews Hospital
Sep 15, 2023

Switching Fluoropyrimidine Due to Cardiotoxicity Study

Enrolling by invitation
  • Solid Tumor
  • Odense, Denmark
  • +12 more
Feb 5, 2020

Chemotherapy Related Cardiotoxicity

Recruiting
  • Cardiotoxicity
  • Gastrointestinal Neoplasms
    • London, United Kingdom
      St Bartholomews Hospital
    Dec 1, 2021

    Chemotherapy-induced Cardiotoxicity.

    Recruiting
    • Cardiotoxicity
    • +2 more
    • Blood sampling
    • +4 more
    • Prague, Czechia
    • +1 more
    Aug 15, 2023

    Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)

    Not yet recruiting
    • Cardiotoxicity
    • +3 more
    • São Paulo, Brazil
      Instituto do Coração
    Aug 16, 2023

    Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)

    Recruiting
    • Doxorubicin Induced Cardiomyopathy
    • Atorvastatin 40 Mg Oral Tablet
    • Placebo
    • Cairo, Egypt
      Ain Shams University hospitals
    Apr 4, 2023

    Cardiotoxic Medication Use Due to Sodium Arsenite Chloride

    Recruiting
    • Adverse Reaction
    • +2 more
    • Sodium arsenite chloride injection
    • Jinan, Shandong, China
    • +1 more
    Sep 23, 2023

    Colorectal Tumors Trial in United States (GRT-C901, GRT-R902, Atezolizumab)

    Recruiting
    • Colorectal Neoplasms
    • Gilbert, Arizona
    • +46 more
    Jan 31, 2023

    Cancer Treatment-Related Cardiotoxicity

    Completed
    • Cardiotoxicity
      • Minneapolis, Minnesota
        University of Minnesota
      Oct 15, 2022

      Breast Cancer, Non Hodgkin Lymphoma Trial in Middlesbrough (Enalapril)

      Recruiting
      • Breast Cancer
      • Non Hodgkin Lymphoma
      • Middlesbrough, Teesside, United Kingdom
        South Tees Hospitals NHS FT
      Oct 20, 2022

      Cancer, Heart Failure, Arrhythmia Trial in Harbin (Control group:DH001 , Trial group: DH001 low-dose group, Trial group: DH001

      Recruiting
      • Cancer
      • +4 more
      • Control group:DH001 placebo
      • +2 more
      • Harbin, Heilongjiang, China
        Harbin Institute of Hematology and Cancer
      Oct 20, 2023

      Metastatic Colorectal Cancer Trial (CA102N, TAS-102, Bevacizumab)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • (no location specified)
      Sep 8, 2023

      Cardiac Toxicity, Early-stage Breast Cancer Trial in United States (Lipitor 40mg Tablet)

      Suspended
      • Cardiac Toxicity
      • Early-stage Breast Cancer
      • Lipitor 40mg Tablet
      • Elizabeth, New Jersey
      • +9 more
      Oct 4, 2022

      Breast Cancer Trial in Seoul (Extracorporeal shock waves)

      Recruiting
      • Breast Cancer
      • Extracorporeal shock waves
      • Seoul, Yangcheon Gu, Korea, Republic of
        Kiwhan Kim
      Oct 25, 2022

      Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

      Active, not recruiting
      • Metastatic Colorectal Cancer
      • Regorafenib (Stivarga, BAY73-4506)
      • Hyderabad, Andhra Pradesh, India
      • +12 more
      Jan 13, 2023

      Cardiotoxicity Trial in Moscow (Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the

      Recruiting
      • Cardiotoxicity
      • Remote 1-minute single-lead electrocardiogram (ECG) monitoring in cancer patients after the first polychemotherapy cycle.
      • Moscow, Russian Federation
        I.M. Sechenov First Moscow State Medical University (Sechenov Un
      Jan 7, 2023

      Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • mCRC
      • Tislelizumab & Fruquintinib
      • Guangzhou, Guangdong, China
      • +1 more
      Jan 25, 2023

      Cancer Trial in Ann Arbor (DPYD or UGT1A1 variants)

      Not yet recruiting
      • Cancer
      • DPYD or UGT1A1 variants
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Dec 20, 2022

      Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

      Recruiting
      • Rectal Cancer
      • Kineret 100 MG in 0.67 ML Prefilled Syringe
      • +3 more
      • Frankfurt, Germany
        University Hospital Goethe University Frankfurt
      Aug 23, 2022

      Healthy Trial in Little Rock (Dexrazoxane)

      Recruiting
      • Healthy
      • Little Rock, Arkansas
        University of Arkansas for Medical Sciences
      Mar 15, 2022

      sociated Cardiotoxicity Basing on PET/CT in Lymphoma

      Not yet recruiting
      • Positron-Emission Tomography
        • (no location specified)
        Jun 6, 2022

        Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in Copenhagen, Odense

        Recruiting
        • Esophageal Squamous Cell Carcinoma
        • +2 more
        • Copenhagen, Region H, Denmark
        • +1 more
        Aug 10, 2022

        Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)

        Not yet recruiting
        • Breast Cancer
        • +12 more
        • Opole, Opolskie, Poland
        • +3 more
        Jul 15, 2022

        Immune Checkpoint Inhibitor-related Cardiotoxicity

        Not yet recruiting
        • Immune Checkpoint Inhibitors, Cardiotoxicity
        • Cardiac magnetic resonance
        • (no location specified)
        Nov 10, 2023

        Breast Tumors Trial in Granada (ATOPE-B, ATOPE-I)

        Recruiting
        • Breast Neoplasms
        • ATOPE-B
        • ATOPE-I
        • Granada, Spain
          University of Granada
        May 25, 2022